Annual Report

Definium Therapeutics, Inc. Filed 2022-03-28 Acc 0000950170-22-004724

Documents 1

2023-03-09 10-K Annual Report
2022-03-28 4 Chief Legal Officer&Secretary acquired 1,200,000 shares (grant or award)
2022-03-28 4 Executive President acquired 600,000 shares (grant or award)
2022-03-28 4 Chief Medical Officer acquired 950,000 shares (grant or award)
2022-03-28 4 Chief Executive Officer acquired 1,820,000 shares (grant or award)
2022-03-28 8-K Results of operations · Auditor change
2022-03-28 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading mnmd-20211231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…